Boehringer Ingelheim has presented data at the 2016 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting showing that the Spiriva Respimat tiotropium bromide soft mist inhaler improves lung function and reduces exacerbations when added to other treatments for all allergic asthma subtypes. The addition of Spiriva Respimat also improved asthma … [Read more...] about BI presents data showing Spiriva Respimat effective when added to other asthma therapies
News
Tim Freeman receives Richard S. Ladd Standards Development Award from ASTM
Powder testing specialist Freeman Technology has announced that Managing Director Tim Freeman has received the Richard S. Ladd Standards Development Award from the ASTM for development of ASTM Standard Designation D7891 “Standard Test Method for Shear Testing of Powders using the Freeman Technology FT4 Powder Rheometer Shear Cell.” Freeman's FT4 powder rheometer is … [Read more...] about Tim Freeman receives Richard S. Ladd Standards Development Award from ASTM
Cannabinoid developer to collaborate with intranasal delivery company on epilepsy therapy
Australian medical cannabis company MGC Pharmaceuticals has signed a collaboration agreement with Israeli device developer SipNose for development of a cannabinoid therapy for the treatment of epilepsy, the company said. The agreement includes an option for a global license for use of the SipNose device to deliver cannabinoids for epilepsy. According to MGC, the … [Read more...] about Cannabinoid developer to collaborate with intranasal delivery company on epilepsy therapy
Study shows significant overdiagnosis of asthma in children
A study published in the British Journal of General Practice titled "Overdiagnosis of asthma in children in primary care: a retrospective analysis" found that over half of children diagnosed with asthma at several major healthcare centers in the Netherlands probably do not have the disease. Researchers from Julius Health Care Center and University Medical Center … [Read more...] about Study shows significant overdiagnosis of asthma in children
Savara Pharmaceuticals raises $20 million for AeroVanc development
Savara Pharmaceuticals has announced the completion of a $20 million financing round to fund a pivotal Phase 3 clinical trial of its AeroVanc vancomycin DPI for the treatment of MRSA lung infections in cystic fibrosis patients. The company says that it expects enrollment for the study to begin by the end of the year. In February 2015, Savara announced positive … [Read more...] about Savara Pharmaceuticals raises $20 million for AeroVanc development
Impel NeuroPharma licenses intranasal therapy for depression
Intranasal delivery specialist Impel NeuroPharma and the Toronto-based Centre for Addiction and Mental Health (CAMH) have signed a licensing agreement for an intranasal neuropeptide-based therapy for the treatment of depression. The peptide, which was discovered at CAMH, will be delivered using Impel's Precision Olfactory Delivery (POD) device. According to CAMH, … [Read more...] about Impel NeuroPharma licenses intranasal therapy for depression
Alexza Pharmaceuticals signs non-binding letter of intent with Grupo Ferrer
Inhaled drug developer Alexza Pharmaceuticals has signed a non-binding letter of intent and entered into discussions with Grupo Ferrer regarding Ferrer's acquisition offer, the company said. Alexza noted that the letter of intent allows the company to continue to explore other options, and there is no guarantee that it will complete the deal with Ferrer. In … [Read more...] about Alexza Pharmaceuticals signs non-binding letter of intent with Grupo Ferrer
MannKind founder Alfred Mann has died at age 90
MannKind Corporation has announced the death of founder and Chairman Emeritus Alfred Mann at age 90, one week after he stepped down as Chairman of the Board. Mann served as CEO from November 2003 until January 2015 and as Chairman of the Board of MannKind from 2001 until last week. According to the company, Mann's death will have no effect on business activities or … [Read more...] about MannKind founder Alfred Mann has died at age 90
Curida announces alliance with OINDP consultant René Bommer
Norwegian CDMO Curida, which offers a wide range of analytical, development, and manufacturing services for OINDPs, has announced a new strategic partnership with pharmAccel Consulting Director René Bommer. In July 2015, Curida acquired a nasal spray manufacturing facility in Elverum, Norway from Takeda, and the company cites Bommer's expertise in nasal spray … [Read more...] about Curida announces alliance with OINDP consultant René Bommer
Adapt launches Narcan nasal spray in the US
Adapt Pharma has announced the availability of Narcan naloxone hydrochloride nasal spray for the treatment of opioid overdose in the US. Narcan nasal spray was approved by the FDA in November 2015. In 17 of the 50 US states, no prescription is required. According to Adapt, the nasal spray will be available at a discounted price of $37.50 per dose for government … [Read more...] about Adapt launches Narcan nasal spray in the US